Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Daiichi decides not to seek marketing approval for nefiracetam in Japan

March 22, 2002

Multiple phase III trials initiated for NBI-34060 in insomnia

March 21, 2002

Canadian IND approval for buccal morphine in the treatment of pain

March 21, 2002

Encouraging results emerge from pilot phase III trial of Chronogesic

March 20, 2002

Neotrofin protects against neurodegeneration in a rat model of Parkinson's disease

March 20, 2002

Once-weekly antidepressant safe and effective in natural clinical setting

March 20, 2002

PARP inhibitors and their uses presented by Ono

March 19, 2002

Betaferon therapy shows sustained benefits and tolerability over 12 years

March 19, 2002

Potent analgesic effect demonstrated for duloxetine in an animal model of persistent pain

March 19, 2002

Potential new analgesic agent with an improved side effect profile under study at UCB

March 18, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 22, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.